Whalesbook
Incorporated in 1995, Nectar Lifesciences Ltd manufactures APIs and Formulations[1]
Business Overview:[1]NLL is a research-driven manufacturerof Active Pharmaceutical Ingredients, intermediates, and finished dosageforms, specializing in anti-infectiveslike Cephalosporins. It also servesas a CMO for global pharmainnovators.
| S.No. | Name | Current Price (Rs.) | Price to Earning | Market Capitalization (Rs.Cr.) | Dividend yield (%) | Net Profit latest quarter (Rs.Cr.) | YOY Quarterly profit growth (%) | Sales latest quarter (Rs.Cr.) | YOY Quarterly sales growth (%) | Return on capital employed (%) | Sales (Rs.Cr.) | OPM (%) | Profit after tax (Rs.Cr.) | Profit after tax latest quarter (Rs.Cr.) | Price to book value | Return on assets (%) | Debt to equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Sun Pharma.Inds. | 1818.30 | 37.81 | 436512.69 | 0.88 | 3124.95 | 2.56 | 14478.31 | 8.93 | 20.21 | 54964.01 | 30.12 | 11543.96 | 3117.95 | 5.61 | 12.97 | 0.07 |
| 2. | Divi's Lab. | 6469.00 | 69.11 | 171747.59 | 0.46 | 689.00 | 35.10 | 2715.00 | 16.12 | 20.44 | 10029.00 | 32.37 | 2485.00 | 689.00 | 11.14 | 13.53 | 0.01 |
| 3. | Torrent Pharma. | 3795.70 | 59.34 | 128559.89 | 0.84 | 591.00 | 32.49 | 3302.00 | 14.30 | 27.05 | 12248.00 | 32.60 | 2166.53 | 600.17 | 15.20 | 13.26 | 0.33 |
| 4. | Cipla | 1521.00 | 22.58 | 122853.86 | 0.85 | 1353.37 | 3.73 | 7589.44 | 7.64 | 22.72 | 28349.57 | 25.40 | 5441.14 | 1351.17 | 3.73 | 14.72 | 0.01 |
| 5. | Dr Reddy's Labs | 1277.60 | 18.48 | 106643.70 | 0.63 | 1336.80 | 7.28 | 8828.30 | 9.83 | 22.69 | 34310.00 | 24.64 | 5772.20 | 1347.10 | 2.96 | 12.95 | 0.16 |
| 6. | Lupin | 2092.00 | 22.09 | 95531.68 | 0.57 | 1484.83 | 73.34 | 7047.51 | 24.23 | 21.30 | 24750.69 | 27.25 | 4324.63 | 1477.92 | 4.87 | 12.41 | 0.32 |
| 7. | Zydus Lifesci. | 935.75 | 18.70 | 94062.77 | 1.18 | 1238.60 | 40.92 | 6123.20 | 16.92 | 24.31 | 24493.90 | 31.10 | 5029.35 | 1283.60 | 3.72 | 14.64 | 0.38 |
| 8. | Nectar Lifesci. | 20.94 | – | 468.29 | 0.00 | -176.01 | -43.48 | 5.71 | -0.52 | -5.36 | 896.63 | -12.35 | -123.26 | -0.33 | 0.66 | -5.37 | 0.64 |
| – | Median: 148 Co. | 409.77 | 31.79 | 1710.39 | 0.12 | 12.57 | 12.32 | 152.64 | 10.54 | 14.85 | 582.87 | 15.93 | 44.55 | 13.49 | 3.18 | 8.39 | 0.22 |
Standalone figures in ₹ crores
| Dec 2022 | Dec 2023 | Dec 2024 | Jun 2023 | Jun 2024 | Jun 2025 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 344 | 452 | 455 | 394 | 359 | 5 | 389 | 441 | 431 | 389 | 398 | 6 | 6 |
Expenses | 343 | 410 | 410 | 359 | 319 | 6 | 369 | 393 | 585 | 396 | 371 | 6 | 6 |
Operating Profit | 1 | 42 | 45 | 36 | 40 | -1 | 20 | 49 | -154 | -7 | 27 | -1 | -0 |
Other Income | 13 | 0 | 1 | 0 | 1 | -62 | 18 | 1 | 0 | 11 | 11 | 7 | -176 |
Profit before tax | -18 | 2 | 13 | 3 | 5 | -64 | 3 | 11 | -188 | -32 | 2 | 5 | -176 |
Tax % | -47% | 36% | 38% | 41% | 40% | -1% | -68% | 95% | -31% | -31% | 38% | -2% | -0% |
Net Profit | -9 | 2 | 8 | 2 | 3 | -63 | 5 | 1 | -130 | -22 | 1 | 6 | -176 |
EPS in Rs | -0.41 | 0.07 | 0.35 | 0.08 | 0.13 | -2.82 | 0.24 | 0.03 | -5.80 | -1.00 | 0.05 | 0.25 | -7.85 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,634 | 1,638 | 1,675 | 1,635 | 1,873 | 2,781 | 2,360 | 1,539 | 1,664 | 1,522 | 1,682 | 1,664 | 897 |
Expenses | 1,345 | 1,371 | 1,436 | 1,411 | 1,637 | 2,517 | 2,142 | 1,430 | 1,506 | 1,467 | 1,530 | 1,694 | 1,007 |
Operating Profit | 289 | 267 | 239 | 224 | 236 | 264 | 218 | 109 | 159 | 55 | 152 | -30 | -111 |
Other Income | 12 | 20 | 6 | 23 | 6 | 6 | 4 | -22 | 11 | 43 | 15 | 5 | -237 |
Interest | 138 | 126 | 123 | 117 | 115 | 148 | 126 | 112 | 79 | 79 | 87 | 75 | 35 |
Depreciation | 84 | 77 | 57 | 62 | 64 | 63 | 61 | 60 | 57 | 59 | 61 | 62 | 32 |
Profit before tax | 78 | 85 | 64 | 67 | 63 | 59 | 36 | -85 | 34 | -41 | 18 | -162 | -415 |
Net Profit | 62 | 66 | 54 | 55 | 52 | 47 | 30 | -73 | 25 | -22 | 5 | -114 | -361 |
EPS in Rs | 2.77 | 2.95 | 2.42 | 2.46 | 2.33 | 2.11 | 1.34 | -3.26 | 1.13 | -1.00 | 0.22 | -5.07 | -16.12 |
Dividend Payout % | 4% | 3% | 4% | 2% | 2% | 2% | 4% | -0% | -0% | -0% | -0% | -0% | – |
Standalone figures in ₹ crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
Reserves | 905 | 936 | 932 | 984 | 1,036 | 1,082 | 1,112 | 1,038 | 1,064 | 1,042 | 1,047 | 934 | 694 |
Borrowings | 858 | 925 | 962 | 878 | 955 | 903 | 779 | 903 | 860 | 754 | 636 | 582 | 459 |
Other Liabilities | 609 | 628 | 640 | 696 | 710 | 696 | 719 | 423 | 443 | 371 | 486 | 509 | 639 |
Total Liabilities | 2,394 | 2,510 | 2,557 | 2,581 | 2,724 | 2,704 | 2,632 | 2,387 | 2,390 | 2,189 | 2,191 | 2,047 | 1,815 |
Fixed Assets | 948 | 934 | 906 | 881 | 852 | 825 | 785 | 772 | 723 | 662 | 643 | 633 | 28 |
Gross Block | 1,341.15 | 1,451.42 | 1,383.66 | 1,420.94 | 1,456.36 | 1,490.50 | 1,508.81 | 1,555.70 | 1,562.95 | 1,557.96 | 1,599.41 | 1,652.17 | – |
Accumulated Depreciation | 393.61 | 517.69 | 478.08 | 539.70 | 604.00 | 665.68 | 723.96 | 783.81 | 839.85 | 895.99 | 956.71 | 1,019.06 | – |
CWIP | 122 | 91 | 99 | 102 | 100 | 100 | 115 | 99 | 85 | 78 | 66 | 57 | -0 |
Investments | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Other Assets | 1,324 | 1,485 | 1,551 | 1,597 | 1,771 | 1,778 | 1,732 | 1,515 | 1,580 | 1,449 | 1,482 | 1,357 | 1,786 |
Total Assets | 2,394 | 2,510 | 2,557 | 2,581 | 2,724 | 2,704 | 2,632 | 2,387 | 2,390 | 2,189 | 2,191 | 2,047 | 1,815 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operating Activity | 255 | 144 | 169 | 199 | 65 | 239 | 286 | 21 | 95 | 133 | 225 | 169 |
Cash from Investing Activity | -90 | -60 | -77 | -18 | -29 | -26 | -33 | -29 | 17 | 52 | -17 | -42 |
Cash from Financing Activity | -161 | -61 | -89 | -204 | -40 | -201 | -252 | 11 | -119 | -186 | -205 | -128 |
Net Cash Flow | 4 | 23 | 3 | -24 | -4 | 12 | 1 | 4 | -8 | -0 | 2 | -1 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 84 | 99 | 107 | 112 | 119 | 74 | 61 | 89 | 98 | 67 | 82 | 76 |
Inventory Days | 240 | 253 | 260 | 270 | 226 | 150 | 192 | 185 | 197 | 212 | 215 | 184 |
Days Payable | 139 | 146 | 154 | 167 | 142 | 79 | 104 | 108 | 112 | 100 | 127 | 117 |
Cash Conversion Cycle | 185 | 207 | 213 | 215 | 203 | 145 | 149 | 166 | 183 | 178 | 170 | 143 |
Working Capital Days | 23 | 40 | 41 | 46 | 67 | 46 | 53 | 6 | 73 | 77 | 63 | 43 |
ROCE % | 12% | 11% | 10% | 10% | 9% | 10% | 8% | 3% | 5% | -0% | 6% | -5% |
Direct from BSE filings, auto-summarised
External media mentions & references
Editorial & research coverage
